Clinical Trials in Portland

Showing 5721-5740 of 10,048 trials

A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis

NCT00811499

This is a Phase 2 study, involving a 12-week treatment period, designed to evaluate the effectiveness of investigational study drug ARRY-371797 (versus placebo) in treating ankylosing spondylitis, and to further evaluate the drug's safety. Approximately 130 patients from the US, Canada, Poland and Hungary will be enrolled in this study.

Ankylosing Spondylitis

Pfizer25 participantsStarted Dec 2008

Los Angeles, California, United States • Chicago, Illinois, United States • Omaha, Nebraska, United States +9 more locations

COMPLETEDPhase 2< 1 mile

Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS)

NCT02460679

This is an open label study with 30-day run in phase to establish baseline parameters, 90-day treatment phase, and a 90-day withdrawal phase to determine long-term effects, duration of treatment response, and potential effects of EPI-589 therapy on known trajectory.

Amyotrophic Lateral Sclerosis

PTC Therapeutics19 participantsStarted Jan 2016

Los Angeles, California, United States • San Francisco, California, United States • Portland, Oregon, United States

A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis

Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Find Trials by Condition in Portland

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

Exercising Together During Radiation Treatment

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

Placenta Imaging Project

Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With Ibrutinib

A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema

Iron Isomaltoside/Ferric Derisomaltose vs Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)

Copper IUD Treatment Observation Study

Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis

BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease

Single Arm on the Tolerability of Weekly Nab-paclitaxel

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice

A Study of ARRY-334543 in Patients With Advanced Cancer

A Study of GDC-0853 in Participants With Refractory Chronic Spontaneous Urticaria (CSU).

Dose-response Relationship Study of S42909 on Leg Ulcer Healing

Study the Efficacy and Safety of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)

Extension Study of Ataluren (PTC124) in Cystic Fibrosis